Regulus Therapeutics Inc. - COM (RGLS)

Historical Portfolio Holders from Q1 2016 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
6.47M
Holdings value Q2 2024
$11.6M
Value change Q2 2024
$0
Grand Portfolio weight change Q2 2024
0%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 6.47M $11.6M $0 $1.79 1
2024 Q1 6.47M $18.6M +$13M $2.88 1
2023 Q4 1.95M $2.49M $0 $1.28 1
2023 Q3 1.95M $2.67M $0 $1.37 1
2023 Q2 1.95M $2.86M +$736K $1.47 1
2023 Q1 1.45M $1.22M $0 $0.85 1
2022 Q4 1.45M $1.98M -$1 $1.37 1
2022 Q3 1.45M $2.46M $0 $1.70 1
2022 Q2 1.45M $2.99M -$40.7M $2.07 1
2022 Q1 60.7M $18.1M +$9.81M $0.30 38
2021 Q4 30.2M $9.54M -$1.03M $0.32 38
2021 Q3 23M $15.9M -$143K $0.69 39
2021 Q2 23.1M $18.7M -$7.72M $0.81 43
2021 Q1 27.3M $42.6M +$15M $1.56 42
2020 Q4 18.4M $24.8M +$14.5M $1.35 28
2020 Q3 7.81M $4.01M +$669K $0.51 21
2020 Q2 6.33M $4.31M -$1.06M $0.68 28
2020 Q1 8.62M $3.97M +$672K $0.46 21
2019 Q4 7.15M $6.37M -$308K $0.89 18
2019 Q3 7.71M $5.55M -$1.72M $0.72 21
2019 Q2 9.06M $11.3M +$8.03M $1.25 20
2019 Q1 2.65M $2.71M +$42.5K $1.02 21
2018 Q4 2.62M $2.44M +$2.32M $0.92 20
2018 Q3 127K $25K +$25K $0.20 1
2016 Q2 0 $0 -$1K 0
2016 Q1 833 $1K $0 $1.20 1